NEW YORK (Reuters Health) – Lower serum levels of creatinine are associated with increased risk of type 2 diabetes, according to a brief report in the March issue…
NEW YORK (Reuters Health) – Treatment with bezafibrate for patients with coronary heart disease appears to reduce long-term mortality, new research indicates. The drug’s ability to raise HDL-cholesterol…
NEW YORK (Reuters Health) – Although the incidence of health care-associated Clostridium difficile infections remained stable in Canada between 1997 and 2005, the attributable mortality nearly quadrupled, according…
NEW YORK (Reuters Health) – Whether or not insulin therapy is used, normalizing glucose levels in hospitalized patients with myocardial infarction (MI) can improve survival, according to a…
NEW YORK (Reuters Health) – As a treatment strategy for early Parkinson disease, initial therapy with levodopa versus pramipexole appears to make little difference in terms of eventual…
NEW YORK (Reuters Health) – High blood pressure accounts for some of the disproportionately higher mortality rates among African American patients with breast cancer compared with Caucasian patients,…
NEW YORK (Reuters Health) – New research suggests that metabolic syndrome, primarily the abdominal obesity component, is associated with lung function impairment. Moreover, the degree of obesity need…
NEW YORK (Reuters Health) – In the real-world setting of contemporary clinical cardiology practices, adverse events following percutaneous cardiovascular procedures are substantially reduced by using radial artery access…
NEW YORK (Reuters Health) – An analysis of data from the Health Professionals Follow-up Study confirms that men with diabetes mellitus are less prone to develop prostate cancer…
NEW YORK (Reuters Health) – Rituximab appears to be of benefit to some patients with severe proliferative or membranous lupus nephritis, according to a small French study published…
